Apr 22 |
Should Weakness in Innoviva, Inc.'s (NASDAQ:INVA) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
|
Mar 4 |
Armata enters $35M credit agreement with Innoviva
|
Mar 4 |
Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva
|
Feb 29 |
Innoviva GAAP EPS of $0.76, revenue of $85.84M beats by $10.32M
|
Feb 29 |
Innoviva Inc (INVA) Reports Growth Amidst Challenges in Q4 and Full Year 2023 Financial Results
|
Feb 29 |
Innoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company Progress
|
Feb 14 |
Jim Simons Bolsters Position in Innoviva Inc with Recent Acquisition
|
Jan 10 |
If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names
|
Dec 30 |
Innoviva's (NASDAQ:INVA) investors will be pleased with their 29% return over the last three years
|
Nov 18 |
Insider Sell Alert: Marianne Zhen Offloads Shares of Innoviva Inc
|